関連する実験動画
Updated: Jun 21, 2026

11:12
Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
Published on: October 17, 2013
心臓弁の義肢を持つ患者の抗血栓管理:現在の証拠と将来の傾向
Jack C J Sun1, Michael J Davidson, Andre Lamy
1Division of Cardiac Surgery, McMaster University, Hamilton, ON, Canada. sunjc2@mcmaster.ca
Lancet (London, England)
|August 18, 2009
まとめ
義手心弁は生活を改善しますが,血栓を防ぐために抗血栓療法が必要です. 新しい進歩は,特に,上昇する弁性心疾患に直面している開発途上国のために,希望を提供します.
科学分野:
- 心臓病学 心臓病学
- バイオメディカルエンジニアリング
背景:
- 世界中で400万人以上が人工心臓弁を持ち,年間30万件が埋め込まれています.
- 義肢弁は,重症な弁性心疾患の生存率を高めます.
- 抗血栓治療は,バルブ受容者にとって極めて重要ですが,挑戦的です.
研究 の 目的:
- 心臓弁義肢患者の抗血栓治療法をレビューする.
- 血栓塞栓性合併症の管理について話し合います.
- 弁膜性心疾患の管理における満たされていないニーズを特定する.
主な方法:
- 抗血栓性療法に関する文献レビュー.
- 現在の義肢バルブ技術の分析.
- バルブ性心疾患における世界的な傾向の評価.
主要な成果:
- 抗血栓性治療は,血栓性合併症を予防するために不可欠です.
- 治療とバルブ技術の進歩は,患者の治療結果を改善しています.
- 開発途上国は,病気の負担が増加しているため,介入の重要な分野を表しています.
結論:
- 改善された抗血栓剤戦略とバルブ技術は,世界中の患者に恩恵をもたらします.
- 特に発展途上国において,満たされていない需要は依然として大きい.
- 将来の取り組みは,弁膜性心疾患の先進的な治療法への公平なアクセスを重視すべきである.
関連する概念動画
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Endocarditis III: Medical Management
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...